SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-005069
Filing Date
2019-01-23
Accepted
2019-01-23 20:48:37
Documents
1
Period of Report
2019-01-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8814
  Complete submission text file 0001209191-19-005069.txt   10375
Mailing Address NO. 14 EAST HUSHAN ROAD TAI'AN CITY SHANDONG F4 000000
Business Address
Cui Xiangmin (Reporting) CIK: 0001487815 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 19538497

Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations